Skip to main content
. 2020 Jan 14;7(2):190–195. doi: 10.4103/apjon.apjon_54_19

Table 2.

Characteristics associated with fall-related self-efficacy (univariate analysis)

Variables Fall-related self-efficacye P

Low (n=40) High (n=41)
Age, mean±SD 63.8±10.2 63.1±11.7 0.789a
Gender, n (%)
 Male 15 (38.5) 25 (61.0) 0.044
 Female 24 (61.5) 16 (39.0)
BMI (kg/m2), n (%)
 <18.5 11 (27.5) 3 (7.3) 0.019
 ≥18.5, <25 21 (52.5) 33 (80.5)
 ≥25 8 (20.0) 5 (12.2)
Employment status, n (%)
 Employed 12 (30.8) 18 (43.9) 0.225
 Unemployed 27 (69.2) 23 (56.1)
Marital status, n (%)
 Married 32 (80.0) 32 (78.0) 0.829
 Others 8 (20.0) 9 (22.0)
Number of household members, n (%)
 Two or more 31 (79.5) 35 (85.4) 0.489
 One only (alone) 8 (20.5) 6 (14.6)
Painc, n (%)
 No 13 (32.5) 24 (58.5) 0.033
 Mild 16 (40.0) 13 (31.7)
 Moderate to severe 11 (27.5) 4 (9.8)
Fatiguec, n (%)
 No 6 (15.4) 11 (26.8) 0.012
 Mild 13 (33.3) 22 (53.7)
 Moderate to severe 20 (51.3) 8 (19.5)
History of falls within the last month, n (%)
 Yes 12 (30.0) 5 (12.2) 0.049
 No 28 (70.0) 36 (87.8)
CIPNd, median (IQR) 30 (15.5) 15 (11) <0.001b

at-test, bMann-Whitney U test, and χ2 test, cNo: NRS 0, mild: NRS 1-3, moderate to severe: NRS ≥4, dCAS for CIPN in survivors of cancer scores, eFSE scale scores. BMI: Body mass index, CIPN: Chemotherapy-induced peripheral neuropathy, SD: Standard deviation, IQR: Interquartile range, CAS: Comprehensive assessment scale, FSE: Falling self-efficacy, NRS: Numeric rating scale. Missing data were excluded.